George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBakkavor Regulatory News (BAKK)

Share Price Information for Bakkavor (BAKK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 115.00
Bid: 115.00
Ask: 117.00
Change: -2.50 (-2.13%)
Spread: 2.00 (1.739%)
Open: 120.50
High: 120.50
Low: 115.00
Prev. Close: 117.50
BAKK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full year 2022 trading update

19 Jan 2023 07:00

RNS Number : 1850N
Bakkavor Group PLC
19 January 2023
 

Full year 2022 trading update

Solid performance in line with expectations, executing our clear plan to protect future profits

Bakkavor Group plc (the "Company") and its subsidiaries ("Bakkavor" or "the Group"), the leading international provider of fresh prepared food ("FPF"), today updates on trading for the 53 weeks to 31 December 2022 ("FY22"), ahead of the publication of its full year results on 8 March 2023.

£ million 

Reported

revenue

53 weeks 

Growth 

Like-for-like1 ('LFL') revenue

52 weeks 

LFL growth 

Group

2,139.2

14.3%

2,069.0

10.6%

UK 

1,783.1

12.0%

1,752.3

10.0%

US 

255.3

41.8%

226.2

25.6%

China 

100.8

1.7%

90.5

(8.6)%

 

Robust growth, performance in line with market expectations and strong balance sheet

· Group reported revenue exceeded £2bn for the first time, up 14.3% on the prior year and LFL revenue up 10.6%. Driven primarily by price in the UK, along with strong volume growth in the US, while Covid impacted volumes in China.

· FY22 Group adjusted operating profit remains in line with market expectations2. Whilst we have been successful in largely mitigating inflation through pricing and internal levers, there has been some impact on profits, which are down year-on-year.

· This reflects a solid performance in the UK; market share gains underpinned by high service levels and breadth of product portfolio, and Christmas trading in line with expectations and well-executed operationally.

· In the US, performance was impacted by disruption from taking on board volume growth and, as reported in our Q3 2022 trading update, a contractual dispute with a customer at one site since November. In China, profitability continued to be impacted by Covid.

· Investment in our people, through pay increases and engagement activities, has had a positive impact, and wider labour market pressures eased through the year.

· We delivered progress against sustainability commitments including through refrigeration upgrades and energy initiatives, along with targeted action on food waste.

· Strong balance sheet maintained; leverage within target range, significant liquidity headroom, and good level of protection against interest rate rises.

A clear plan to protect profits in 2023, with actions underway

· As significant headwinds will persist in our markets through 2023, we have implemented a Group-wide plan to protect profits, as previously announced.

· Our plan, which includes a leaner organisation structure, refreshed clear and focused regional priorities, and enhanced emphasis on managing cash, will deliver savings of £15m in FY23, and £25m on an annualised basis.

· Actions are well progressed with the new Management Board and leadership structure established, the UK business operationally consolidated from four to two sectors, Meals and Bakery, and the consultation at two UK sites concluded, on track to close and transfer volume in H1 2023.

· In the US, we have a renewed focus on operational performance to improve margin sustainably and whilst near-term challenges remain in China, we are well-positioned to capitalise on the future growth opportunity when conditions normalise.

· The cash costs of implementing the plan are expected to be c.£20m, with most of the cash outflow in FY23. These costs, together with c.£35m of non-cash impairment charges3, will be recognised as exceptional items in FY22.

· This decisive action, combined with our scale and breadth, customer relationships and balance sheet strength provide us with a stronger platform to move forward with purpose and confidence.

 

Mike Edwards, CEO, commented:

"Despite 2022 being another challenging year, Bakkavor delivered a robust performance and once again demonstrated the strength of our customer relationships and the resilient foundations of our business. The relentless commitment and agility that our people have shown set us apart through this difficult period, and I would like to thank everyone for their hard work.

"Whilst market challenges will persist in 2023, the actions we are taking to protect profits, our clear strategy and our balance sheet strength, allow us to move forward with purpose and confidence, enabling us to deliver on our medium- to long-term ambitions."

 

 

1. LFL revenue is revenue from continuing operations adjusted for the revenue generated from businesses closed or sold in the current and prior year, revenue generated from businesses acquired in the current and prior period, and the effect of foreign currency movements. FY22 included 53 weeks of trading, compared to 52 weeks in FY21. LFL revenue excludes the 53rd week in FY22. All other FY22 measures include the 53rd week.

2. Based on company compiled consensus ("Consensus") which includes; Berenberg, Citi, Goodbody, HSBC, Investec, Kepler, Numis and Peel Hunt. Adjusted operating profit Consensus for 2022 of £88.6m, with a range of £86.7m to £90.3m.

3. Non-cash impairment charges of c.£35m include c.£21m from the closure of two UK sites, a c.£10m impairment of our investment in associate in Hong Kong due to the ongoing impact of Covid on trading performance, and the balance relates to an impairment of inventory and receivables associated with the contractual dispute with a US customer.

 

ENQUIRIES

Institutional investors and analysts:

Ben Waldron, Chief Financial Officer

Emily Daw, Head of Investor Relations +44(0)20 7908 6114

Financial media: bakkavor@mhpgroup.com

Katie Hunt, MHP +44(0)20 3128 8794

Rachel Farrington, MHP +44(0)20 3128 8613

Oliver Hughes, MHP +44(0)20 3128 8622

 

About Bakkavor

We are the leading provider of fresh prepared food ("FPF") in the UK, and our presence in the US and China positions the Group well in these, high-growth markets. We leverage our consumer insight and scale to provide innovative food that offers quality, choice, convenience, and freshness. Over 19,000 colleagues operate from 46 sites across our three markets supplying a portfolio of over 3,200 products across meals, pizza & bread, salads and desserts to leading grocery retailers in the UK and US, and international food brands in China.

LEI number: 213800COL7AD54YU9949

Disclaimer - forward-looking statements

This statement includes forward-looking statements. By their nature, forward-looking statements involve risk, uncertainty and other factors, which may cause the actual results and developments of the Group to differ materially from any results and developments expressed or implied by such forward-looking statements. You should not place undue reliance on any forward-looking statements. These forward-looking statements are made as of the date of this statement. The Group is under no obligation to publicly update or review these forward-looking statements other than as required by law.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDZGMMNRGGFZM
Date   Source Headline
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
2nd Apr 20241:15 pmRNSDirector Declaration
26th Mar 20241:00 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSAnnual Report and Accounts 2023 and Notice of AGM
5th Mar 20244:56 pmRNSFinal Dividend for Full Year 2023
5th Mar 20247:00 amRNSFull Year Results 2023
18th Jan 20247:00 amRNSFull Year 2023 Trading Update
15th Jan 20247:17 amRNSMajor Shareholder Change and Directorate Change
15th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSHolding(s) in Company
11th Jan 20243:48 pmRNSHolding(s) in Company
9th Oct 20233:37 pmRNSDirector/PDMR Shareholding
21st Sep 202312:07 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSHalf-year Report
20th Jul 202310:07 amRNSDirector Declaration
31st May 20233:11 pmRNSResult of AGM
31st May 20237:00 amRNSQ1 2023 Trading Update
23rd May 20237:00 amRNSDirector/PDMR Shareholding
10th May 20235:16 pmRNSDirector/PDMR Shareholding
13th Apr 20239:54 amRNSDirector/PDMR Shareholding
3rd Apr 20234:05 pmRNSDirector/PDMR Shareholding
29th Mar 202311:57 amRNSHolding(s) in Company
17th Mar 20237:00 amRNSAnnual Report and Accounts 2022 and Notice of AGM
8th Mar 20237:00 amRNSFull Year Results 2022
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
19th Jan 20237:00 amRNSFull year 2022 trading update
18th Jan 20236:00 pmRNSRPS Group
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
23rd Nov 20227:00 amRNSQ3 2022 trading update
18th Nov 20227:00 amRNSBoard Committee Membership Changes
13th Oct 20224:05 pmRNSDirector/PDMR Shareholding
10th Oct 20224:35 pmRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSDirectorate Change
21st Sep 20224:41 pmRNSSecond Price Monitoring Extn
21st Sep 20224:35 pmRNSPrice Monitoring Extension
12th Sep 20224:36 pmRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20224:41 pmRNSSecond Price Monitoring Extn
22nd Aug 20224:35 pmRNSPrice Monitoring Extension
9th Aug 20224:36 pmRNSPrice Monitoring Extension
11th Jul 20224:36 pmRNSPrice Monitoring Extension
22nd Jun 20224:36 pmRNSPrice Monitoring Extension
7th Jun 20227:30 amRNSDirector Declaration
30th May 20224:36 pmRNSPrice Monitoring Extension
27th May 20222:03 pmRNSDirector/PDMR Shareholding
25th May 20223:09 pmRNSResult of AGM
25th May 20221:38 pmRNSDirector/PDMR Shareholding
25th May 20227:00 amRNSQ1 2022 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.